6 01, 2024 Matteo Pallocca et al., Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres adlitterio663392024-01-06T14:53:04+01:00 Mehr erfahren
3 01, 2024 Michele Simbolo et al., Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectives adlitterio663392024-04-10T15:44:30+02:00 Mehr erfahren
3 01, 2024 Federica Grillo et al., BRAFV600E immunohistochemistry can reliably substitute BRAF molecular testing in the Lynch syndrome screening algorithm in colorectal cancer adlitterio663392024-01-03T14:49:53+01:00 Mehr erfahren
1 01, 2024 Margareta Radi? Antolic et al., U?estalost idh1/2 mutacija u bolesnika s dijagnozom akutne mijeloi?ne leukemije – pilot studija kbc zagreb adlitterio663392024-10-07T16:08:24+02:00 Mehr erfahren
1 01, 2024 Andrea Boscolo Bragadin et al., Integrating clinico-pathological features and longitudinal liquid biopsy results to predict clinical benefit from immune checkpoint Inhibitors in advanced Non-Small Cell Lung Cancer patients adlitterio663392024-01-01T14:40:45+01:00 Mehr erfahren
1 01, 2024 Filippo Nozzoli et al., Morpho-phenotypic characterization of melanoma brain metastases immune microenvironment: A multicentre retrospective study adlitterio663392024-01-01T11:34:27+01:00 Mehr erfahren
28 12, 2023 Qian Meng et al., Excessive erythrophagocytosis accounts for systemic inflammation in chronic kidney disease adlitterio663392024-04-29T10:02:50+02:00 Mehr erfahren
27 12, 2023 Eva Lieto et al., Assessment of the DNA Mismatch Repair System Is Crucial in Colorectal Cancers Necessitating Adjuvant Treatment: A Propensity Score-Matched and Win Ratio Analysis adlitterio663392023-12-27T16:46:13+01:00 Mehr erfahren
21 12, 2023 Oleksandr Dudin et al., Incidence of BRAF mutations in cutaneous melanoma: histopathological and molecular analysis of a Ukrainian population adlitterio663392023-12-21T17:03:44+01:00 Mehr erfahren
21 12, 2023 Shooting Cancer Highlights – Monthly focus on regulatory status of new targeted therapies in oncology – November 2023 adlitterio663392023-12-21T10:08:16+01:00 Mehr erfahren
